Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/24/14 → 3/31/18 |
Funding
- PRA Health Sciences (Prot #PCYC-1121-CA // Prot #PCYC-1121-CA)
- Pharmacyclics, Inc. (Prot #PCYC-1121-CA // Prot #PCYC-1121-CA)
Prot #PCYC-1121-CA: A Multicenter, Open-Label, Phase 2 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Subjects with Relapsed/Refractory Marginal Zone Lymphoma
- Ma, Shuo (PD/PI)
Project: Research project